Immunome Announces Pricing of Public Offering of Common Stock

Core Viewpoint - Immunome, Inc. has announced a public offering of 18,625,000 shares of its common stock priced at $21.50 per share, with all shares being sold by the company [1] Company Summary - The public offering aims to raise gross proceeds for Immunome, which will be used for its targeted cancer therapies development [1] - The offering is underwritten, indicating that a financial institution is involved in the sale of the shares [1]